United States: FDA Issues Final Guidance on General Wellness Products

On July 28, 2016, the United States Food and Drug Administration (FDA) finalized guidance stating that the agency does not plan to regulate "general wellness products," including software applications, provided they present a low risk to the safety of users and other persons. Under this policy, FDA will not regulate many products that the agency believes meet the statutory definition of a "device" and thus could be subject to FDA regulation. Manufacturers or developers of products that may meet the definition of general wellness products should carefully consider the limitations of this policy, with particular focus on whether their advertising claims fall within the "intended use" definitions set forth in the guidance.

Importance of "Intended Use"

Like the draft guidance, the final guidance explains that FDA will not apply either pre- or post-market regulatory requirements to "general wellness products" that pose a low risk to a user's or another person's safety. Examples of such products include software programs, exercise equipment, audio recordings, video games, personal fitness trackers, sleep monitors, and other products, including mobile applications, commonly available from retail establishments or downloaded from online sources. 

General wellness products, for the purposes of the guidance, must fall into one of two categories, based on "intended use." The intended use of a product is determined primarily by the advertising and promotional claims the manufacturer or distributor makes for the product, although it may also be determined by other circumstances surrounding the product's marketing, sale, or distribution. Under the guidance, the intended use of a general wellness product must either:

  1. relate to maintaining or encouraging a general state of health or a healthy activity, without any reference to particular diseases or conditions, or 
  2. relate to the role of a healthy lifestyle by helping to reduce the risk or impact of certain chronic diseases or conditions, where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition.

The first category is the simpler of the two to understand because it draws a bright line: it entirely excludes products not intended to address specific diseases or conditions. Such products might promote, for example, weight management, stress management, or sexual function, but without referring to particular diseases such as obesity, anxiety disorders, or erectile dysfunction. Arguably, even without this guidance document, many such products would fall outside the statutory definition of a medical device. 

The second category presents more interpretive challenges. It addresses products intended to promote, track, or encourage choices that, as part of a healthy lifestyle, "may help reduce the risk of" or "may help living well with" certain chronic diseases or conditions. The guidance states that, to fall within the intended use of a general wellness product, such lifestyle choices must be "well accepted" as playing an important role in helping patients with the particular disease or condition. FDA states that this category would apply, for example, to a software app that claims to promote physical activity, which, as part of a healthy lifestyle, may help reduce the risk of high blood pressure. Other examples FDA provides of chronic diseases for which a healthy lifestyle is associated with risk reduction or help in living well with that disease include heart disease and type 2 diabetes. FDA also provides specific examples of software apps intended to help users live well as part of a healthy lifestyle with migraine headaches and anxiety. We anticipate that many companies seeking to promote products for specific diseases or conditions will need to consider carefully whether their products meet the definition of a general wellness product under this category.

FDA also states in the guidance that a general wellness product may "only" be intended for a general wellness use. A product that has a general wellness use but also has other intended uses, therefore, would not be a general wellness product under the guidance and may be subject to FDA regulation.

Focus on Risk

In addition to having a general wellness intended use, FDA states that a product must meet additional "low risk" criteria to fall within the policy of non-regulation. In the final guidance, FDA eliminated the draft guidance's proposal that such products must have "very low" risk. The final guidance also clarifies that a product is not considered low risk, and thus not within the scope of the policy laid out in the guidance, if it (a) is "invasive" (i.e., it penetrates or pierces the skin or mucous membranes), (b) is implanted, or (c) involves technology that may pose a risk to user safety if specific regulatory controls are not applied, such as risks from lasers or radiation exposure. The final guidance eliminates some of the amorphous language that had been included in the draft, which stated that a product would not be considered low risk if it raised "novel questions of usability" or "questions of biocompatibility."

In evaluating risk, FDA recommends that manufacturers and developers consider whether FDA actively regulates products of the same type as the product in question. The guidance also gives a number of examples of products that would not be considered low risk. Examples include:

  • A sunlamp product promoted for tanning purposes, due to risks to a user's safety, including skin cancer.
  • A neurostimulation product that claims to improve memory, due to the risks to a user's safety from electrical stimulation.
  • A product that claims to enhance a user's athletic performance by providing suggestions based on the results of relative lactic acid testing, due to invasive sampling (venipuncture) and risks to other persons if specific regulatory controls are not applied (e.g., venipuncture may pose a risk of infection transmission).

Examples of products that would be considered low risk general wellness devices, by contrast, include:

  • A mobile application that plays music to "soothe and relax" an individual and to "manage stress."
  • A mobile application that solely monitors and records daily energy expenditure and cardiovascular workout activities to allow awareness of one's exercise activities to improve or maintain good cardiovascular health.
  • A mobile app that reminds users to keep exposed skin out of direct sunlight when the UV index is high.
  • A portable product intended to monitor pulse rate during exercising or hiking.
  • A product intended to mechanically exfoliate the face, hands, and feet to make the skin smoother and softer, but that cannot be used in a manner that penetrates the skin.

What's Next?

The latest FDA guidance contributes to FDA's efforts to clarify its policies regarding the regulation of products that potentially meet the definition of a medical device, with particular focus on the rapidly expanding market for digital health applications and products. This guidance is part of a broader effort by the agency to clarify its digital health policies, which have also been addressed in FDA's guidance documents on Mobile Medical Applications, Medical Device Data Systems, and medical device accessories. Another draft guidance document expected to be forthcoming would address clinical decision support (CDS) tools, and is expected to continue the general "de-regulatory" trend in the digital health area.

Developers of health-related software and other general wellness products also should bear in mind that they remain subject to other key federal and state laws and regulations. These include advertising and privacy requirements enforced by the Federal Trade Commission (FTC), product safety rules enforced by the Consumer Product Safety Commission (CPSC), HIPAA protections against unauthorized disclosure of protected health information enforced by the Department of Health and Human Services' Office of Civil Rights (HHS OCR), and state false advertising and consumer protection statutes enforced by state Attorneys General. For example, a Federal Trade Commission (FTC) action against Focus Education, a company that claimed its video games lessen the symptoms of Attention Deficit Hyperactivity Disorder, shows the importance of ensuring that all claims of health-related benefits are well substantiated.

Click here to read the FDA's notice in the Federal Register regarding the publication of its final guidance.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.